Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
oxygen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
oxytocin and misoprostol
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
pancrelipase with bicarbonate
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial -
phosphatidylcholine
Ultragenyx UK Limited
Methionine Adenosyltransferase Deficiency
1 trial -
plasmalyte solution
Hospital Authority, Hong Kong
Cardiac Surgery
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
Colonoscopy: Bowel Preparation
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
IBD (Inflammatory Bowel Disease)
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
remimazolam
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthetic Drug Adverse Reaction
1 trial -
sevelamer hydrochloride
The University of Hong Kong
Endstage Renal Disease
1 trial -
sodium bicarbonate Ringer's solution
The First People's Hospital of Lianyungang
Hepatic Ischemia
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
succimer
Ultragenyx UK Limited
Lead Poisoning
1 trial -
telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)
Praxis Precision Medicines
Telemedicine
1 trial -
the ginsenoside Rg3
The First People's Hospital of Lianyungang
Stage I Hepatocellular Carcinoma
1 trial -
the usage of Olverembatinib combined with Inotuzumab Ozogamicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ph+ ALL
1 trial -
therapeutic progesterone
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
thioctic acid
Ultragenyx UK Limited
Mitochondrial Myopathy
1 trial -
thyrotropin-releasing hormone
Ultragenyx UK Limited
Respiratory Distress Syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources